Post-marketing clinical study conducted on a CE medical device, named Defense Body, cellulite treatment, edematous fibrosclerotic panniculopathy (2nd and 3rd stage pathology), reducing draining cream-gel, to verify its effectiveness and tolerability on a panel of 56 subjects females affected by 2nd and 3rd degree PEF. The effectiveness of the device is measured in terms of reduction in thigh circumference, improvement in the appearance of the skin with reduction of the orange peel appearance and improvement in skin smoothness.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
First day of study initiation: clinical history; personal and demographic data and previous or concomitant treatments
Timeframe: First day: within 24 hours
First day of study initiation: BMI
Timeframe: First day: within 24 hours
First day of study initiation: Measurement of waist circumference, hip circumference and thigh circumference
Timeframe: First day: within 24 hours
First day of study initiation: digital photographs of the area to be treated
Timeframe: First day: within 24 hours
First day of study initiation: skin profilemetry of the thigh
Timeframe: First day: within 24 hours
First day of study initiation: pinch test
Timeframe: First day: within 24 hours